FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Mylan Pharmaceuticals Acamprosate Calcium Recall

Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Myl…

Mylan Pharmaceuticals Inc · Morgantown, WV

Risk level
Class II
Reported by FDA
Aug 26, 2026
Recall ID
D-0774-2026
Check your lot numberHow we source this data

Summary

Mylan Pharmaceuticals recalled Acamprosate Calcium starting Jul 24, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0774-2026 on Aug 26, 2026. Reason: Failed Dissolution Specifications. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications

Product description

Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.

Lot numbers, UPCs & expiration codes

Lot# 3227809; Expiry:10/2026; NDC #: 0378-6333-80

Where it was sold

US Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0774-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 24, 2026
FDA report date
Aug 26, 2026
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0774-2026, exactly as published.

Show all FDA fields
City
Morgantown
State
WV
Status
Ongoing
Country
United States
Event ID
99483
Address
3711 Collins Ferry Rd
Code information
Lot# 3227809; Expiry:10/2026; NDC #: 0378-6333-80
Postal code
26505-2362
Report date
Aug 26, 2026
Product type
Drugs
Recall number
D-0774-2026
Classification
Class II
Recalling firm
Mylan Pharmaceuticals Inc
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.
Distribution pattern
US Nationwide.
Recall initiation date
Jul 24, 2026
Initial firm notification
Letter
Center classification date
Aug 19, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0774-2026, published Aug 26, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls